EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial

Tao Mei iD, Jianing Li, Xiangang Yang iD

PLOS One · 10.11.2026 · 21 (11) · e0361864

DOI: 10.1371/journal.pone.0361864 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 10.11.2026. Verfasst von Tao Mei und 2 weiteren Autor:innen. Beteiligte Einrichtung: China Institute of Sport and Health Science, Beijing Sport University, Beijing, China. Hauptthemen laut MEDLINE: Caffeine, Running, Athletic Performance. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Humanities and Social Sciences Research Project of the Ministry of Education of China, Zhejiang “Pioneer” and “Leading Goose” R&D Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence is limited on whether commonly used caffeine doses provide uniform benefits across sprint phases and performance outcomes in trained sprinters. We compared the acute effects of 3 and 6 mg/kg caffeine in a randomized, double-blind, placebo-controlled, three-condition crossover trial. Twenty-one male 100-m sprinters completed placebo, 3 mg/kg caffeine, and 6 mg/kg caffeine trials separated by at least 7 days. Sixty minutes after ingestion, participants completed two maximal 60-m sprints, followed by countermovement jump, squat jump, and 10-s Wingate tests. Sprint times, derived split times, start reaction time, starting-block rate of force development, stride variables, and perceived exertion were also assessed. Linear mixed-effects models adjusting for treatment period and randomized sequence showed clear treatment effects for cumulative 10-, 30-, and 60-m times (all p < 0.001). Relative to placebo, 3 mg/kg shortened these times by 0.056, 0.083, and 0.123 s, whereas 6 mg/kg shortened them by 0.075, 0.115, and 0.175 s. Compared with 3 mg/kg, 6 mg/kg further reduced 30- and 60-m times by 0.032 and 0.052 s, respectively, whereas the additional 0.019-s reduction at 10 m was not statistically significant in the primary mixed-effects model. Both doses improved reaction time, perceived exertion, jump height, Wingate peak and mean power, and starting-block rate of force development relative to placebo. Additional benefits of 6 mg/kg were evident for jump height and rate of force development, but not for reaction time, perceived exertion, or Wingate mean power; Wingate peak power did not improve further with the higher dose. Stride length and frequency were unchanged. These findings indicate outcome-specific dose responses, with 3 mg/kg improving multiple performance outcomes and 6 mg/kg providing additional benefits most consistently for vertical jump height, starting-block rate of force development, and cumulative performance over the first 60 m. Trial registration Chinese Clinical Trial Registry, ChiCTR2600128594 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaffeineRunningAthletic PerformanceHumansMaleDouble-Blind MethodCross-Over StudiesYoung AdultAdultDose-Response Relationship, Drug

Substanzen

Caffeine

Autor:innen und Institutionen

  • China Institute of Sport and Health Science, Beijing Sport University, Beijing, China.
  • Beijing Key Laboratory of Sports Performance and Skill Assessment, Beijing Sport University, Beijing, China.
  • Key Laboratory for Performance Training and Recovery of the General Administration of Sport of China, Beijing Sport University, Beijing, China.
  • Football College, Hebei Sport University, Shijiazhuang, China.

ORCID-Profile: Tao Mei, Xiangang Yang

Förderung

  • Humanities and Social Sciences Research Project of the Ministry of Education of China
  • Zhejiang “Pioneer” and “Leading Goose” R&D Program

Zitieren

APA

Mei, T., Li, J., & Yang, X. (2026). Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial. PLOS One, 21(11), e0361864. https://doi.org/10.1371/journal.pone.0361864

Vancouver

Mei T, Li J, Yang X. Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial. PLOS One. 2026;21(11):e0361864. doi:10.1371/journal.pone.0361864

BibTeX
@article{Mei2026,
  author = {Mei, Tao and Li, Jianing and Yang, Xiangang},
  title = {Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0361864},
  doi = {10.1371/journal.pone.0361864}
}
Kostenlos starten →